Post by Gilead Sciences

836,004 followers

When it comes to metastatic triple-negative breast cancer (mTNBC), innovation cannot wait. Hear what oncologists, researchers, and advocates have to say about why advancing treatment options for metastatic TNBC is so critical.

Post content

Video Content